Jump to Content
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search within results
Search within results
Filter
Filter
Refine by Subjects
Clinical Resources
(1,337)
Drug Information
(932)
Educational & Training
(267)
Pharmacy Practice
(19)
Refine by Access
All content
Content accessible to me
Refine by Type
Books
(21)
Chapters
(1,316)
Submit
Refine by Date
From
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
—
To
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2009
2008
2002
Submit
Print
Save
Email this link
Share Link
Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:
https://publications.ashp.org/collection/ClinicalResources?access=all&page=13&pageSize=50&sort=datedescending&t_0=ClinicalResources
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
Browse
You are looking at
601
-
650
of
1,337
items for
:
Clinical Resources
x
Refine by Access: All content
x
Clear All
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
8
9
10
11
12
13
14
15
16
17
18
...
Restricted access
CH 2.8 Unfractionated Heparin and Low Molecular Weight Heparins
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
15 UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARINS, AND FONDAPARINUX
A. Joshua Roberts, Hahyoon Kim, and William E. Dager
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
Ursodiol Suspension 20 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ursodiol Suspension 25 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ursodiol Suspension 30 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ursodiol Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ursodiol Syrup 60 mg/mL—Formulation 1*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ursodiol Syrup 60 mg/mL—Formulation 2*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Valacyclovir Hydrochloride Suspension 50 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Valganciclovir Hydrochloride Suspension 30 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Valganciclovir Hydrochloride Suspension 60 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
21 VALPROATE
Barry E. Gidal
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
CH 1.12 Valproic Acid
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 2.12 Valproic Acid
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
Valsartan Suspension 4 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Valsartan Suspension 4 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
22 VANCOMYCIN
Jeremiah J. Duby, Monica A. Donnelley, Chelsea L. Tasaka, and Brett H. Heintz
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
CH 1.13 Vancomycin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 2.13 Vancomycin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
Vancomycin Hydrochloride Ophthalmic Solution 31 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Vancomycin Hydrochloride Suspension 25 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Vancomycin Hydrochloride Syrup 25 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Verapamil Hydrochloride Suspension 50 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Voriconazole Ophthalmic Solution 1 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Voriconazole Ophthalmic Solution 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Voriconazole Suspension 40 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
23 WARFARIN
Sara R. Vazquez
Chapter
In
Clinical Pharmacokinetics
Published (Print):
01 Jan 2022
Restricted access
CH 1.14 Warfarin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
CH 2.14 Warfarin
John E. Murphy
Chapter
In
Clinical Pharmacokinetics Workbook
Published (Print):
01 Jan 2022
Restricted access
24 Women’s Health
Candi C. Bachour
Chapter
In
Basic Skills in Interpreting Laboratory Data
Published (Print):
01 Jan 2022
Restricted access
Zidovudine Syrup 10 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Ziprasidone Mesylate Syrup 2.5 mg/mL
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Zonisamide Suspension 10 mg/mL—Formulation 1
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Zonisamide Suspension 10 mg/mL—Formulation 2
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Restricted access
Zonisamide Syrup 10 mg/mL*
Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes
Chapter
In
Extemporaneous Formulations
Published (Print):
Jan 2022
Free access
Abciximab
AHFS 20:12.18
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Acetaminophen
AHFS 28:08.92
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Acetazolamide Sodium
AHFS 52:40.12
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Acetylcysteine
AHFS 92:12
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Acyclovir Sodium
AHFS 8:18.32
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Adenosine
AHFS 24:04.04.24
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Albumin Human
AHFS 16:00
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Aldesleukin
AHFS 10:00
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Alfentanil Hydrochloride
AHFS 28:08.08
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Allopurinol Sodium
AHFS 92:16
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Alprostadil
AHFS 92:16 AHFS 24:12.92
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Alteplase
AHFS 20:12.20
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Amifostine
AHFS 92:56
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Amikacin Sulfate
AHFS 8:12.02
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Restricted access
Amino Acids
AHFS 92:16 AHFS 40:20
Chapter
In
ASHP® Injectable Drug Information™
Published (Print):
Jan 2021
Items per page:
10
20
50
Sort by:
Title A - Z
Title Z - A
Author A - Z
Author Z - A
Date - Old to Recent
Date - Recent to Old
Page: ...
8
9
10
11
12
13
14
15
16
17
18
...
[18.97.14.88]
18.97.14.88